SenzaGen AB (STO:SENZA)

Sweden · Delayed Price · Currency is SEK

5.34

0.00 (0.00%)

Jul 20, 2026, 4:47 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Toxicology in Vitro Testing	57.97M	57.70M	49.87M	41.77M	15.42M
Toxicology in Vitro Testing Growth	0.48%	15.69%	19.39%	170.85%	93.79%
Total	57.97M	57.70M	49.87M	41.77M	15.42M
Total Growth	0.48%	15.69%	19.39%	170.85%	93.79%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sweden	2.04M	1.25M	-	41.77M	15.42M
Sweden Growth	63.15%	-	-	170.85%	93.79%
France	8.59M	11.53M	-	-	-
France Growth	-25.48%	-	-	-	-
Italy	7.74M	7.93M	-	-	-
Italy Growth	-2.28%	-	-	-	-
Rest of Europe	20.38M	21.20M	-	-	-
Rest of Europe Growth	-3.85%	-	-	-	-
United States (US)	18.29M	13.64M	-	-	-
United States (US) Growth	34.04%	-	-	-	-
Rest of World	932.00K	2.15M	-	-	-
Rest of World Growth	-56.71%	-	-	-	-
Total	57.97M	57.70M	-	41.77M	15.42M
Total Growth	0.48%	-	-	170.85%	93.79%